The Vagus Nerve and CIRS: What the Research Actually Says

By Miles Harlow · Updated September 20, 2026

If you've spent any time reading about CIRS, you've almost certainly run into the vagus nerve. It gets blamed for why symptoms stick around, and it gets targeted with everything from cold plunges and humming to breathing protocols and ear-clip devices.

It's easy to dismiss all of that as wellness marketing. But underneath it there's a genuine piece of neuroscience, and it's worth understanding.

So what's actually going on here?

The short version is that the vagus nerve really does control inflammation, through a circuit that has been mapped in detail and tested in people. What nobody has done is measure that circuit in anyone with CIRS.

That gap matters, and it's the honest starting point for everything below.

What does the vagus nerve do?

The vagus nerve is the main line of communication between your organs and your brainstem, and traffic runs in both directions.

About 80% of its fibers are sensory, carrying information from your organs up to your brain. The rest run downward, to the heart, lungs and gut.

Most people only hear about the downward half, the part that slows your heart rate and drives digestion. "Vagal tone" refers to how active that calming signal is.

But the sensory half is the more interesting one here. The vagus nerve is how your brain finds out what's happening in your body, including what your immune system is doing.

Vagal tone is usually estimated using heart rate variability (HRV), the small beat-to-beat variation in your heart rate. Because the vagus nerve adjusts your heart rate breath by breath, more variability generally means more vagal activity.

How does the vagus nerve control inflammation?

Through a circuit researchers call the inflammatory reflex. The nerve detects inflammatory signals in the body, and then sends a signal back that tells immune cells to stop producing inflammatory chemicals.

Most of this was worked out in Kevin Tracey's lab. In a 2000 paper in Nature, researchers showed that acetylcholine, the vagus nerve's main chemical messenger, sharply reduced the release of inflammatory cytokines including TNF, IL-1β and IL-6 from human immune cells.

Interestingly, it left IL-10 alone. IL-10 is the main anti-inflammatory cytokine, so the circuit seems to suppress inflammation selectively rather than shutting the immune system down across the board.

When the same team stimulated the vagus nerve electrically in rats exposed to a lethal dose of bacterial toxin, TNF levels dropped and the animals didn't go into shock.

The last step turned out to be stranger than expected. Nerve fibers in the spleen can't actually produce acetylcholine, so there was a missing link in the chain.

A 2011 paper in Science found it: a specialized group of T cells in the spleen that make acetylcholine themselves. Remove those cells, and stimulating the vagus nerve no longer suppresses inflammation.

So the nerve doesn't switch off inflammation directly. It signals immune cells, and they release the chemical that does.

Does this actually work in people?

Yes, at least in rheumatoid arthritis, which is the strongest human evidence that this circuit can be deliberately controlled.

A 2016 study found that stimulating the vagus nerve reduced production of TNF, IL-1β and IL-6 in people who already had implanted stimulators, and improved disease severity in people with rheumatoid arthritis.

That study was small and uncontrolled, though. The better test came later.

RESET-RA, published in Nature Medicine in 2026, randomized 242 people with rheumatoid arthritis to either active stimulation or a sham device for three months. At three months, 35.2% of the active group hit the standard improvement threshold, compared with 24.2% on sham.

Two things are worth noticing there.

The first is that nearly a quarter of people improved on a device that wasn't doing anything, which tells you how much apparent benefit any plausible-looking treatment can produce.

The second is that the real difference was about 11 percentage points. That's a genuine effect, but it's a modest one. This is a mechanism you can nudge, not a switch that turns inflammation off.

The researchers also described the inflammatory reflex as "dysregulated" in rheumatoid arthritis, which is the idea worth carrying into CIRS: a chronic inflammatory illness can involve a control circuit that isn't doing its job.

Could the vagus nerve explain CIRS symptoms?

It's a genuinely interesting possibility, because the symptoms the vagus nerve produces line up closely with what people with CIRS describe.

When the vagus nerve detects inflammation in the body, it signals the brain to produce what researchers call sickness behavior: fatigue, low mood, withdrawal, loss of appetite, aching, and trouble concentrating.

That's not a figure of speech. It's a coordinated biological response, and part of it travels through the vagus nerve.

The evidence for the vagal part is quite specific. In a 2000 study in rats, injecting an inflammatory cytokine caused the animals to withdraw from normal social behavior. Cutting the vagus nerve blunted that effect.

But cutting the nerve didn't stop the fever.

That split is useful. It suggests the fatigue-and-brain-fog cluster and the classic signs of inflammation travel by different routes, which means a nerve-carried sickness signal could be running strongly even when standard inflammatory markers don't look dramatic.

Michael VanElzakker turned this into a formal proposal for chronic fatigue syndrome in a 2013 paper. His idea was that if the vagus nerve's own sensory tissue is inflamed, the nerve keeps sending a sickness signal regardless of how much inflammation exists elsewhere in the body.

That paper is a hypothesis, published in a journal for hypotheses, and it hasn't been tested. But it describes a mechanism that could produce a persistent sickness state without obvious systemic inflammation, and it would apply to CIRS just as readily.

Is the vagus nerve actually involved in CIRS?

Nobody knows, because nobody has measured it. There's no published study of vagal function, heart rate variability, or the inflammatory reflex in people with CIRS.

That's worth saying plainly, because the vagus nerve often gets discussed in CIRS circles as though the connection were settled.

What we have instead is a set of facts that fit together reasonably well.

CIRS involves persistent innate immune activation. A 2006 study of 26 people with illness from water-damaged buildings found elevated MMP9 in 22 of them, which the researchers read as evidence of an ongoing inflammatory response, alongside abnormal leptin, MSH and VEGF.

The inflammatory reflex exists specifically to limit that kind of ongoing activation. So if inflammation is persisting for months or years, it's reasonable to ask whether the circuit that should be shutting it down is working properly.

And the symptoms overlap closely. Sickness behavior is fatigue, cognitive difficulty, low mood and aching, which covers a good portion of the CIRS symptom list.

That's a solid case for investigating. It isn't a finding.

Does low MSH connect CIRS to the vagus nerve?

Possibly, and this is the most specific link between standard CIRS lab findings and vagal biology. It also hasn't been tested in anyone with CIRS.

Low MSH (alpha-melanocyte stimulating hormone) is one of the most consistently reported CIRS lab abnormalities. In the study above, MSH was abnormal in 25 of 26 patients.

Here's the connection. MSH belongs to a family of peptides called melanocortins, and melanocortins can activate the same anti-inflammatory pathway the vagus nerve uses.

A 2010 review summarizes the animal work: melanocortin peptides protect animals in shock and other severe conditions, and they appear to do it by switching on the vagal anti-inflammatory pathway through receptors in the brain.

If that holds in people, low MSH would mean weaker activation of that pathway, which would mean less suppression of inflammation, which would help explain why the inflammation persists.

It's a more coherent idea than the VIP argument you'll sometimes see, which I looked at in the article on mold and acid reflux and which runs in the wrong direction.

The limits are real, though. The melanocortin research is in animals, in acute conditions like shock, not chronic low-grade inflammation. Nobody has shown that CIRS-level MSH deficits are enough to weaken this pathway, or that correcting MSH changes anything.

So it's a plausible, specific, untested idea. Which is exactly the kind of thing that should be easy to test.

Can mold exposure damage the vagus nerve?

There's no evidence that mold exposure damages the vagus nerve, and no study has looked. But there's a more plausible version of the question.

The vagus nerve supplies the airways heavily. Its sensory endings there detect irritants and inflammatory chemicals, and they drive the cough reflex.

Mold exposure inflames those airways. So the nerve endings most exposed to a moldy building are sitting in inflamed tissue.

Airway nerves become more sensitive when the surrounding tissue is inflamed. That's the accepted explanation for why chronic cough persists, and I covered the version of it that drives reflux in the acid reflux article.

So a sensitized nerve after mold exposure is plausible and fits what we know about cough. Actual structural damage to the nerve is a different claim, and nothing supports it.

The distinction matters for what you'd expect next. A sensitized nerve can settle down once the input stops. Damage wouldn't.

Can CIRS cause dysautonomia or POTS?

People with CIRS commonly report symptoms that look like dysautonomia. Autonomic function has never been measured in a CIRS population, so nobody can say whether they have it.

Dysautonomia means the autonomic nervous system, which runs your body's automatic functions, isn't regulating properly. POTS is one specific form, defined by an excessive jump in heart rate when you stand up.

The symptoms CIRS patients describe fit that picture: lightheadedness on standing, racing heart, temperature intolerance, digestive problems.

And since the vagus nerve is one half of the autonomic system, low vagal tone would be expected to produce roughly this cluster.

What's missing is anyone actually checking. Tilt-table testing and HRV measurement are standard and widely available, and they've simply never been applied to a CIRS group in published research.

Does low heart rate variability mean you have inflammation?

Lower HRV is associated with higher inflammatory markers, but the relationship is modest, and HRV is a rough proxy rather than a measurement of inflammation.

A 2019 meta-analysis pooled 51 studies and found that as vagally-mediated HRV goes down, inflammatory markers tend to go up.

The researchers were careful about it. They noted the findings were mixed, with some studies showing the opposite, and that only certain HRV measures showed a consistent relationship.

Their conclusion was appropriately modest: HRV can be used as an index of the pathway that regulates inflammation. Not that low HRV proves you're inflamed, and not that raising it will bring inflammation down.

That's worth keeping in mind if you're tracking HRV on a wearable during CIRS recovery. A rising trend is consistent with improving autonomic regulation, but it isn't a measurement of your inflammation, and daily readings swing heavily with sleep, alcohol, exercise and illness.

Do vagus nerve treatments help with CIRS?

No treatment aimed at the vagus nerve has been tested in CIRS. The evidence comes from other conditions, and it splits sharply depending on the method.

Implanted stimulation has real evidence behind it, as RESET-RA showed. The devices you can actually buy are another matter. Ear-clip stimulators failed a 113-person sham-controlled trial in rheumatoid arthritis, scoring 25.0% against 26.9% for the sham.

Same disease, same target, opposite results. A surgically placed cuff on the vagus nerve is not the same thing as a clip on your ear.

I've broken all of this down device by device in do vagus nerve stimulation devices work?

Slow breathing is the other common recommendation. Breathing at around six breaths a minute does reliably raise HRV, which is a real autonomic effect.

But "raises HRV" and "lowers inflammation" are two different claims, and only the first one has been demonstrated. The ear-clip trial is a good warning here: a device delivering actual current to an actual vagal branch still couldn't beat a sham.

Slow breathing is free and safe and does something measurable. Treating it as an anti-inflammatory treatment goes well past the evidence.

Cold exposure, humming and gargling have even less behind them. They're recommended based on anatomy rather than on results, and I couldn't find controlled trials testing them against inflammatory markers in any chronic inflammatory illness.

So what does this mean if you have CIRS?

A few things follow from the research, even with the large gaps.

The biology is real, but the CIRS link is untested. Anyone telling you the vagus nerve explains your CIRS is going beyond the evidence. It's a reasonable hypothesis, not an established finding.

Removing the exposure comes first. The inflammatory reflex works like a brake. If something in your environment keeps generating inflammation, working on the brake while the input continues is the wrong order of operations.

This is where vagus nerve framing can actually cause harm. It turns a building problem into a personal-regulation problem, and it's much easier to sell breathing protocols than to remediate a house.

Be skeptical of devices. The consumer ear-clip devices most often recommended for this are the ones that failed their best trial.

HRV is worth watching, loosely. It's a reasonable indicator of autonomic recovery over time. It is not a measurement of inflammation, and single readings tell you very little.

And if you're wondering what research would actually settle this, it isn't complicated. Measuring HRV in a group of people with CIRS and comparing them with matched controls would take a few weeks and has never been done.